Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines

Cisplatin is a highly-effective and widely-used chemotherapeutic agent that causes ototoxicity in many patients. Pharmacogenomic studies of key genes controlling drug biotransformation identified variants in thiopurine methyltransferase (TPMT) as predictors of cisplatin-induced ototoxicity, although...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhavsar, Amit P., Gunaretnam, Erandika P., Li, Yuling, Hasbullah, Jafar S., Carleton, Bruce C., Ross, Colin J. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391095/
https://www.ncbi.nlm.nih.gov/pubmed/28406961
http://dx.doi.org/10.1371/journal.pone.0175711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391095/
https://www.ncbi.nlm.nih.gov/pubmed/28406961
http://dx.doi.org/10.1371/journal.pone.0175711

Ejemplares similares